NCT01678521View on ClinicalTrials.gov

Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Hypercholesterolemia
Interventions
PROCEDURE

LDL-apheresis

The acronym H.E.L.P. stands for Heparin-induced Extracorporeal Low-density-lipoprotein Precipitation. Antecubital veins served as blood access. The mean blood volume processed per session is of approximately 3000 ml.

Trial Locations (1)

37126

Endocrinologia e Malattie Metaboliche, Azienda Ospedaliera Universitaria Integrata Verona, Verona

All Listed Sponsors
lead

Universita di Verona

OTHER

NCT01678521 - Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients | Biotech Hunter | Biotech Hunter